PBG BioPharma, Phytochemical Biopharmaceutical Group, is a vertically integrated biopharmaceutical company focusing on the research, development and manufacturing of both, nutraceutical and cannabis-based pharmaceutical cannabinoids such as (THC, CBD, CBG, CBN, Delta-8 THC). Using its proprietary GenBioChem® triple fingerprinting technology platform, PBG takes a pharmaceutical approach to developing cannabis-based ingredients and other phytochemical-based NHP products. PBG is licensed for Cannabis Processing, Analytical Testing and Cannabis Research and owns multiple manufacturing & laboratory facilities across Alberta & BC, encompassing a total of 70,000 square-ft. of state-of-the-art, FDA and Health Canada approved, GMP standard pharmaceutical / nutraceutical manufacturing sites with a suite of ISO 17025 labs. PBG, being vertically integrated, also owns a pharmacy store (combined with a CBD clinic), to help enhance and drive patient access to medical cannabis. PBG Biopharma employs a team of science, research and technical professionals that bring on decades of experience and a successful track record of innovation and delivery to market: Canada’s #1 leading Natural Cold & Flu remedy, COLD-FX®. Building on this innovation, PBG is conducting further research and therapeutic development in the areas of treating mental illness (depression, anxiety, sleep disorder), broad spectrum anti-viral and chronic pain relief, through phytochemical and nutraceutical product development. PBG offers business solutions through contract manufacturing, analytical, product development services and phytochemical ingredients including cannabinoids and psilocybin. PBG also serves the nutraceutical industry with several products on the market including GenBioChem® line of NHP products including GenBioChem® Immunity, Memory and Energy (Qi). https://pbgbiopharma.com/ https://www.genbiochemhealth.com/